A de novo missense mutation in SLC12A5 found in a compound heterozygote patient with epilepsy of infancy with migrating focal seizures.

A de novo missense mutation in SLC12A5 found in a compound heterozygote patient with epilepsy of infancy with migrating focal seizures.
Clin Genet. 2017 May 06;:
Authors: Saito T, Ishii A, Sugai K, Sasaki M, Hirose S
Abstract
Epilepsy of infancy with migrating focal seizures (EIMFS) is an infantile epileptic encephalopathy characterized by refractory seizures, severe psychomotor delay, and multiple moving epileptic discharges. The genetic etiology of EIMFS is relatively homogeneous with the majority of causative mutations found in KCNT1. Currently, gene panel or whole-exome sequencing is used for testing. To verify the pathogenicity of a variant, co-segregation of the variant and the disorder in a pedigree is important; hence, de novo mutations that are judged to be deleterious may be considered pathogenic because the patients are isolated. In contrast, in cases from non-consanguineous families, genes that cause disorders in a recessive manner should remain as potential candidates. Herein, we performed gene panel sequencing of a patient with EIMFS from a non-consanguineous family, and found a compound heterozygous constellation consisting of a maternally inherited p.Ser399Leu and a de novo p.Arg880Leu in SLC12A5, which encodes the neuronal KCC2 co-transporter. These unique mutations demonstrate gene variants that act in a recessive manner may be pathogenic for patients from non-consanguineous families.
PMID: 28477354 [PubMed ...

Source: Clinical Genetics - May 6, 2017 Category: Genetics & Stem Cells Authors: Saito T, Ishii A, Sugai K, Sasaki M, Hirose S Tags: Clin Genet Source Type: research